NXL Price sensitive 23 Feb 2026, 8:30 AM

1H26 Financial Results Investor Presentation

NUIX Ltd

1H26 Financial Results Investor Presentation

Key points

  • Annualised Contract Value (ACV) $234.4m, up 8.4% on pcp
  • Nuix Neo ACV $46.8m, up 148% on pcp, now representing 20% of total ACV
  • Revenue $121.2m, up 15.2%, driving Adjusted Management EBITDA of $19.1m, up 42.6% on pcp

Full summary

Nuix Ltd reported robust financial results for the first half of FY26, with key highlights including: Annualised Contract Value (ACV) of $234.4m, up 8.4% on the prior corresponding period (pcp); Nuix Neo ACV of $46.8m, up 148% on pcp and now representing 20% of total ACV; revenue of $121.2m, up 15.2% on pcp, driving Adjusted Management EBITDA of $19.1m, up 42.6% on pcp and demonstrating significant operating leverage. The company also reported a lift in cash generation, with positive Underlying and Overall Cash Flow and a closing cash balance of $57.8m. Nuix launched a comprehensive Nuix Neo Migration Program to systematically transition its customer base to the modern platform and drive ACV growth. The powerful combination of Nuix Neo's large-scale forensic data analysis and LLM integration flexibility creates a structural advantage for the company.

Guidance

Nuix maintains its full year ACV range of $240m - $260m, excluding ACV associated with the Linkurious acquisition.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in